Trial reportBMJ open2021
Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial.
Trial report in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02578420 (Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo), which is not on this map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo
Who cites it
12 citing papers in PubMed.
- Open-label placebo treatment does not enhance cognitive abilities in healthy volunteers.Scientific reports · 2023Trial
- Trial
- Trial
- Acceptance of Open-Label Placebos Is Linked to Holistic Health Beliefs and Thinking Styles.Behavioral sciences (Basel, Switzerland) · 2026Article
- Effects of an open-label placebo on divergent thinking performance.Frontiers in psychology · 2026Article
- Article
- Talking placebo: a qualitative study of patients' attitudes toward open-label placebo implementation into clinical practice.Frontiers in psychology · 2025Article
- Effects of Open-Label Placebos on Visual Food Cue Reactivity in Children and Adolescents.Children (Basel, Switzerland) · 2024Article
- Placebo Effects on the Enjoyment of Physical Activity and Performance among Kindergarten Children: A Randomized Controlled Trial.European journal of investigation in health, psychology and education · 2024Article
- Would You Take an Open-Label Placebo Pill or Give One to Your Child? Findings from a Cross-Sectional Survey.Psychology research and behavior management · 2024Article
- Experiences of Patients Taking Conditioned Open-Label Placebos for Reduction of Postoperative Pain and Opioid Exposure After Spine Surgery.International journal of behavioral medicine · 2023Article
- The roles of expectation, comparator, administration route, and population in open-label placebo effects: a network meta-analysis.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo analyse participants' concepts about the open-label placebo (OLP) effect; to explore their views about the discussion points that are applied in conventional OLP trials and to examine their experiences of taking part in an OLP trial.
designA qualitative study using thematic analysis of semistructured interviews that were nested within a randomised controlled trial investigating experimental OLP analgesia (registered at ClinicalTrials.gov: NCT02578420).
participants30 healthy adults who took part in the randomised controlled trial.
resultsParticipants mostly conceptualised placebo as something that is inert and requires deception in order to be effective. Interviewees used a broad definition of placebos, going beyond a conventional notion of sugar pills. In contrast to the conventional OLP rationale, participants seldom emphasised classical conditioning as a mechanism of placebo effects, stressing a variety of other well-established components through which placebos might be therapeutic, whereas the conventional OLP disclosures state that 'a positive attitude helps but is not necessary', participants in our study applied other attitudes, such as 'it's worth a try'. When asked about their experiences during the trial, the majority emphasised that the concept of OLP was completely novel to them. Participants were rather sceptical about the efficacy of the intervention.
conclusionIntegrating lay perspectives into the scientific rationale of OLP treatments might enhance the plausibility and credibility of the rationale in ethical treatments. TRIAL REGISTRATION NUMBER: NCT02578420.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.